Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,454.80 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
Nasdaq 2,837.53 -1.85 -0.07%
Ticker Volume Price Price Delta
STOXX 50 2,161.87 +5.35 0.25%
FTSE 100 5,351.53 +1.48 0.03%
DAX 6,339.94 +24.05 0.38%
Ticker Volume Price Price Delta
Nikkei 8,580.39 +17.01 0.20%
TOPIX 722.11 -0.14 -0.02%
Hang Seng 18,713.40 +47.01 0.25%
Gold 1,571.20 +0.73%
EUR-USD 1.2540 0.1812%
Nasdaq 2,837.53 -0.07%
DJIA 12,454.80 -0.60%
S&P 500 1,317.82 -0.22%
FTSE 100 5,351.53 +0.03%
STOXX 50 2,161.87 +0.25%
DAX 6,339.94 +0.38%
Oil (WTI) 90.86 +0.22%
U.S. 10-year 1.738% -0.039
BAC:US 7.15 +0.14%
FB:US 31.91 -3.39%
  • Exchange: NASDAQ GS
  • Sector: Consumer, Non-cyclical
  • Industry: Healthcare-Products
  • Sub-Industry: Diagnostic Equipment

Cepheid Inc

Add to Portfolio

CPHD:US

38.4700 USD 0.3800 1.00%

As of 20:10:00 ET on 05/25/2012.

Snapshot for Cepheid Inc (CPHD)

Open: 38.1700 Day's Range: 37.7200 - 38.6100 Volume: 354,561 Bid: 38.4600
Previous Close: 38.0900 52wk Range: 29.7100 - 45.0000 1-Yr Rtn: +20.11% Ask: 38.4700

Stock Chart for CPHD

No chart data available.
  • CPHD:US 38.4700
  • 1D
  • 1M
  • 1Y
38.0900
Interactive CPHD Chart

Previous Close

Key Statistics for CPHD

Current P/E Ratio (ttm) -
Estimated P/E (12/2012) 126.5461
Earnings Per Share (USD) (ttm) -0.0800
Est. EPS (USD) (12/2012) 0.3040
Est. PEG Ratio 5.8405
Market Cap (M USD) 2,524.01
Shares Outstanding (M) 65.61
Enterprise Value (M USD) (ttm) 2,420.02
Enterprise Value/EBITDA (ttm) 143.21
Price/Book (mrq) 10.9012
Price/Sale (ttm) 8.3218
Dividend Indicated Gross Yield 0.0000
Next Earnings Announcement 07/20/2012
More CPHD Key Statistics mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Financials for CPHD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)
More CPHD Income Statement Data
  • Total Assets
  • Total Liabilities (M/USD)
  • Debt to Assets (%)
More CPHD Balance Sheet Data
  • Operating
  • Investing
  • Financing (M/USD)
More CPHD Cash Flow Data

Company Profile & Key Executives for CPHD

Cepheid, Inc. is a molecular diagnostics company dedicated to improving healthcare with its molecular systems and tests. The Company enables institutions to access the full power of molecular diagnostics with genetic testing for organisms and genetic-based diseases.

Thomas L Gutshall "Tom"Chairman/Co-FounderJohn L BishopChief Executive Officer
Andrew D MillerExec VP/CFOHumberto ReyesExec VP/COO
More Company Profile & Key Executives for CPHD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements